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Abstract
Curcuminoids, bioactive molecules contained in turmeric, have been reported to exert anticancer effects in
several human cancers, including hepatocellular carcinoma (HCC). However, the extraction method can significantly
affect the structural characteristics of curcuminoids and their biological properties. On this basis, in the present study
we investigated the content of curcuminoids and the anticancer activity of two turmeric powders extracted according
two different methodologies: solvent extraction with ethyl acetate vs an ancient Indian extraction method of boiling of
rhizomes in water followed by dehydration at the sun. Results obtained showed that extraction with ethyl acetate
resulted in a significant recovery of curcuminoids and anticancer activity both in terms of cell cytotoxicity and
migration/invasiveness inhibition in HCC cell lines, compared to common Indian practice. Overall these findings
suggest that turmeric powders could have different efficacy, depending on the extraction method. This aspect should
be taken into account when choosing the best product to be employed in the prevention and treatment of human
diseases, including cancer.
Keywords: Turmeric; Extraction; Curcuminoids; Hepatocellular
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Introduction
Turmeric, the dried ground rhizome of Curcuma longa L., is a spice
cultivated in tropical and subtropical regions, especially in India.
Traditionally, it has been employed in Ayurvedic medicine in light of
its anti-inflammatory properties. However, several in vitro and in vivo
studies have clearly shown that turmeric extracts harbor additional
biological properties, including powerful antioxidant, antibacterial,
anti-viral and antitumoral activities [1]. This large biological activity
sets turmeric extracts as promising molecules for the prevention and
treatment of many human diseases, including cancer [2]. The
biological properties of turmeric extracts are known to be mainly
linked to the content of curcuminoids, bioactive molecules including
curcumin (the principal constituent), demethoxycurcumin and bis-
demethoxycurcumin (Figure 1A). Due to the beneficial health effects,
curcumin and their derivatives have been the object of extensive
investigation in the field of biology, medicine and pharmacology.
However, the potential application of curcuminoids as bioactive
molecules is limited by their low solubility and poor stability [3].
Currently different conventional methodologies are employed to
extract curcuminoids from turmeric, including extraction with
solvents [4-7]. According to the international authorities that monitor
the development of food additives, a limited number of solvents is
allowed for preparation of curcuminoid-based products, in particular
ethyl acetate. Besides conventional methodologies, a traditional Indian
practice is the boiling of rhizomes in water followed by dehydration at
the sun. This practice, along with drying conditions, has been reported
to influence the level of curcuminoids in the rhizomes [8]. Since the
structural characteristics of curcuminoids and their biological
properties can be significantly affected by extraction method [9], in the
present study we compared the efficacy of conventional solvent
extraction with ethyl acetate vs the common Indian extraction in
neutral aqueous solution. The antitumoral properties of the turmeric
powders obtained according to these two different methodologies was
then investigated on HepG2 and Huh-7 human hepatocellular
carcinoma (HCC) cell lines.
Figure 1: A) Chemical structure of curcuminoids; B)
Chromatogram of curcuminoids at 405 nm. For each turmeric
powder (STD, T1 and T2), three different peaks are reported: bis-






l & Aromatic Plants
ISSN: 2167-0412 Medicinal & Aromatic Plants
Deserti et al., Med Aromat Plants (Los Angeles)
2018, 7:6
DOI: 10.4172/2167-0412.1000324
Research Article Open Access
Med Aromat Plants (Los Angeles), an open access journal
ISSN: 2167-0412
Volume 7 • Issue 6 • 1000324
Materials and Methods
Cell culture
The human HCC cell lines Huh-7 and HepG2 were kindly provided
by Dr. Catia Giovanni (Center for Applied Biomedical Research, S.
Orsola-Malpighi University Hospital, Bologna, Italy) and maintained
in Dulbecco’s modified Eagle’s Medium with g/L glucose (Euroclone,
Milan, Italy), supplemented with 10% (v/v) heat-inactivated FBS (Euro
clone), 2 mM L-glutamine, 100 U/ml penicillin and 100 µg/ml
streptomycin (Sigma-Aldrich, St. Louis, MO, USA) in an atmosphere
of 5% CO2 at 37°C.
Turmeric powders
Turmeric powder 1 (T1) was purchased from an Ayurvedic
Laboratory in Nepal. Briefly, raw turmeric rhizomes cultivated in
Nepal at 2000 mt were harvested in June, cleaned to remove hairy roots
and boiled in water for 45 minutes until the rhizomes became soft.
Water was then drained, and the turmeric’s were sun dried for 10-15
days until they became dry and hard. The dried product was cleaned
and polished and finally ground by hand with stone mills. Turmeric
powder 2 (T2) was obtained from an herbalist’s shop located in
Bologna (Italy). It was produced with turmeric rhizome grown in India
and curcuminoids extraction was carried out according to
conventional ethyl acetate method [10]. A turmeric powder containing
a mixture of curcuminoids (99% purity, Sigma-Aldrich, St. Louis, MO,
USA) was used as reference standard (STD). All turmeric powders
were diluted into DMSO to obtain the final concentration before each
experiment.
Curcuminoids LC-UV analysis
STD, T1 and T2 turmeric solutions (1 mg/mL, in methanol) were
diluted 40 folds with water-acetonitrile-FA (99:1:0.1, v/v/v) mixture.
T1 resulted to be not completely soluble in methanol; for this reason,
its solution was filtered with a 0.22 µm filter (Merck KGaA, Darmstadt,
Germany). In details, curcumin was determined using a Jasco
PU-1585HPLC system (Jasco Corporation, Tokyo, Japan) equipped
with a Rheodyne 7281 injection valve (20 µL sample loop). The
detection was performed with a Jasco UV-1575 detector set at 405 nm.
The analysis was performed using an Agilent extend C18
chromatographic column (3.5 µm; 2.1 × 100 mm). The analyses were
performed in isocratic mode using a mobile phase composed of water-
acetonitrile-FA (63:37:0.1, v/v/v). The injection volume was 20 µ L and
the flow rate was 0.5 mL/min. We expected to obtain three different
peaks corresponding to the C. longa curcuminoids: bis-
demethoxycurcumin (A), demethoxycurcumin (B) and curcumin (C).
The peak identity was attributed both by the characteristic relative
abundance of each curcuminoid, both by the elution order in a reverse
phase approach, as reported in literature [11,12].
Cell viability assay
Cell viability experiments were carried out by 3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) assay.
Briefly, Huh-7 and HepG2 cells (5 × 103 cells/well) were plated in a 96-
well plate in triplicate and allowed to adhere for 24 hrs. Cells were then
treated with increasing concentrations (10, 25 and 50 µM) of DMSO or
STD, T1 and T2 turmeric powders for 24, 48 and 72 hrs. At the end of
incubation, MTT was added to each well and cells incubated at 37°C
for 4 h. Formazan crystals were then dissolved by DMSO addition.
Absorbance was then measured at 570 nm in a 96-well
spectrophotometric microplates reader (Bio-Rad, Hercules, CA, USA).
Cell cycle analysis by flow cytometry
For the analysis of DNA content, Huh-7 and HepG2 cells were
seeded on a six-well plate at the density of 4 × 105 cells/well and treated
with DMSO or STD, T1 and T2 turmeric powders at 50 µM
concentration. At different intervals (24, 48, and 72 hrs), cells were
harvested by trypsinization, washed with cold phosphate-buffered
saline (PBS) and incubated at 4°C for 16 h in the DNA-staining
solution (containing 0.1% Triton X-100, 0.1% sodium citrate and 50
µg/ml propidium iodide). At the end of incubation, cells were
harvested, washed in PBS. DNA content analysis was performed by
FACSAria™ cell sorter (Becton Dickinson, Franklin Lakes, NJ).
In vitro wound healing (scratch) assay
Cell motility assay was assessed by wound healing (scratch) assay.
Briefly Huh-7 and HepG2 (4 × 105 cells/well) were seeded in 6-well
plates and allowed to attach to the surface under standard incubation
conditions. After 24 hrs, the confluent cell monolayer was scratched in
a straight line using a 200-µl sterile plastic pipette tip. The cells were
then carefully rinsed with culture medium to remove free-floating cells
and debris. Then 50µM DMSO or STD, T1 and T2 turmeric powders
were added to each well and the effect on wound healing was
monitored. Scratch zones representative for each cell line were
photographed immediately and after 48 hrs of treatment with an
Olympus CK × 41 inverted microscope, equipped with an Olympus
C5060-ADU camera (Olympus, Milan, Italy).
In vitro matrigel invasion assay
Huh-7 and HepG2 invasive potential was assessed by Matrigel
invasion assay. Briefly, 12 µm polyvinylpyrrolidone-free polycarbonate
filters (Millipore Co, Cork, Ireland) were coated with growth factor-
reduced Matrigel (BD Biosciences, Milan, Italy). Complete medium
was placed in the lower chamber as chemo-attractant. Huh-7 and
HepG2 (5 × 105) cells, previously treated for 48 hrs with DMSO or
STD, T1 and T2 turmeric powders at 50 µM, were seeded in the upper
chamber and incubated for 6 hours at 37°C in a humidified 5% CO2.
At the end of incubation, non-invading cells were removed from the
upper surface of the filters, and invading cells in the lower surface were
fixed for 1 min in ethanol 95% and stained for 10 min with 0.5% wt/vol
toluidine blue. For each sample, 4 random optical fields at x200 of total
magnification were analyzed.
Statistical evaluation
Results were expressed as mean or percentage mean ± SD and
reproducibility was confirmed in three separate experiments.
Differences between groups were analyzed using Student t test. Data
were analyzed by Prism 5.0 program and a P value<0.05 was
considered to be statistically significant.
Results
Evaluation of the curcuminoids content in T1 and T2
turmeric powders
We firstly evaluated the curcuminoids content in T1 and T2
turmeric powders; STD turmeric powder was used as reference. For
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this purpose, a reverse-phase HPLC-UV assay was carried out using an
isocratic approach. As described above, for sample preparation 1 mg of
each formulation was solubilized in 1 mL of methanol. STD and T2
powders resulted completely soluble in methanol; conversely T1 was
not completely soluble and its filtration resulted necessary. Therefore,
for T1, a lower purity in terms of curcuminoids content was expected.
The overlaid chromatograms obtained with the LC-UV analyses are
reported in Figure 1B. In all samples, three distinct peaks (a, b and c),
corresponding to the different C. longa curcuminoids, were observed;
in particular, T2 turmeric powder contained the highest quantity of
curcumin. Assuming the peak area of T2 as 100% (Benchmark), the
peak area and, consequently, the curcumin content of STD was
equivalent to the 95%, while that of T1 reached only the 5%.
T2, but not T1, inhibits migration and invasive potential of
HepG2 and HuH-7 cell lines
As already reported, curcuminoids have a strong anti-proliferative
effect on cancer cells [13]. Therefore we tested the effect on HepG2 and
HuH-7 cell viability of increasing concentrations (0-10-25-50 µM) of
STD, T1 and T2 turmeric powders after 24, 48 and 72 hrs of treatment.
As reported in Figure 2A and 2B, a significant time-and dose-
dependent decrease of cell viability was observed in both cell lines
treated with T2 powder, reaching about the 90% in HuH-7 cells and
80% in HepG2 cells after 72 hrs of treatment at the dose of 50 µM.
Conversely, treatment for 72 hrs with T1 powder, also at high
concentrations, did not exert any significant effect on HepG2 and
HuH-7 cell viability. Next, we investigated the effect of T1 and T2
turmeric powders on HepG2 and HuH-7 cell cycle. As shown in Figure
3A, treatment with T2 (but not with T1) powder at the dose of 50 µM
induced a time-dependent increase in the sub-G0 phase, which
represents the fraction of fragmented apoptotic cells. In particular after
72 hrs of treatment, we observed an induction of apoptosis reaching
about 90% of apoptotic cells in HuH-7 and 50% in HepG2 cell lines
(Figure 3B). No significant changes in cell cycle and apoptosis were
instead observed for T1 turmeric powder (Figure 2).
Figure 3: (A) Effect of STD, T1 and T2 turmeric powders (50 µM)
on Huh-7 and HepG2 cell cycle after 24, 48 and 72 hrs of treatment.
The graphs show the percentage of cells in each cycle phase; (B)
Percentage of Huh-7 and HepG2 apoptotic cells after 24, 48 and 72
hrs of treatment with STD, T1 and T2 turmeric powders 50 µM. *
p<0.05; ** p<0.001. CTR: control; STD: standard.
Figure 2: Effect on HuH-7 (A) and HepG2 (B) cell viability of
increasing concentrations (10-25-50 µM) of STD, T1 and T2
turmeric powders after 24, 48 and 72 hrs of treatment. For each cell
line, the mean value of CTR samples was assumed as 100% and
mean values of treated cells were plotted as percentage with respect
to their matched controls. * p<0.05; ** p<0.001. CTR: control; STD:
standard.
Figure 4: (A) Effect of STD, T1 and T2 turmeric powders (50 µM)
on Huh-7 and HepG2 cell migration at time 0 and after 48 hrs of
treatment. Scale bar (50 µm); (B) Evaluation of Huh-7 and HepG2
invasive potential after 48 hrs of treatment with STD, T1 and T2
turmeric powders 50 µM. For each cell line, the mean value of CTR
samples was assumed as 100% and mean values of treated cells were
plotted as percentage with respect to their matched controls. *
p<0.05; ** p<0.001. CTR: control; STD: standard.
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T2, but not T1, inhibits migration and invasive potential of
HepG2 and HuH-7 cell lines
Finally, we evaluated the effect of T1 and T2 powders on HepG2 and
HuH-7 cell migration and invasive potential. Scratch wound-healing
assay revealed a strong ability of T2 powder 50 µM to inhibit cell
migration in both cell lines after 48 hrs of treatment; no significative
changes were instead detectable after treatment with T1 powder
(Figure 4A). Notably, the decrease of HepG2 and HuH-7 cell migration
was found to be associated with a significant reduction of invasiveness
in cells treated with T2, but not T1, powder (Figure 4B).
Discussion
The identification of the extraction method allowing the best
recovery of bioactive curcuminoids represents an intense area of
investigation in the field of phytomedicine. Indeed, the processing
conditions play important roles in determining the quality and efficacy
of the phytopharmaceutical product. In this context, it is of great
interest to undertake studies investigating the relationship between the
extraction method and the biological properties of curcuminoid
extracts. In the present study we investigated the differences in
curcuminoid content and antitumoral properties of two turmeric
powders obtained according to ethyl acetate extraction and to a
common Indian practice of boiling of rhizomes in water followed by
dehydration at the sun. Results obtained in our study clearly showed
that extraction with ethyl acetate resulted in a significant recovery of
curcuminoids from turmeric when compared to the STD reference of
curcuminoid mixture. On the contrary, curcuminoids recovery
accordingly to common Indian practice was found to be negligible.
These findings were in agreement with the results obtained in cell line
functional studies. Indeed, while T2 powder (with a high content of
curcuminoids) showed a strong antitumoral effects in HepG2 and
HuH-7 cell lines both in terms of cell cytotoxicity and migration/
invasiveness inhibition, T1 powder (with a very low content of
curcuminoids) was found to be ineffective against these two
parameters. The different antitumoral efficacy of T1 and T2 powders
could be ascribable to the different capability to extract curcuminoids
in aqueous medium compared to aprotic polar solvents (as ethyl
acetate). Indeed, as already reported, the efficiency of curcuminoid
extraction in pure water is negligible, although it could be increased
adding ethanol. Moreover, curcuminoids mainly exists in the keto-enol
form in aqueous media, where solubility slightly increases but fast
hydrolysis occurs [14]. Overall the present study shows that
curcuminoid extraction in aqueous media (as occurs in Indian
practice) does not represent the best choice for best recovery of
bioactive curcuminoids. Conversely, conventional extraction with ethyl
acetate should be preferred to achieve curcuminoid extracts with
significant biological properties. This aspect should be taken into
account when choosing the best product to be employed in prevention
and treatment of human diseases, including cancer.
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